High-Dose Vitamin C Plus Chemotherapy vs Chemotherapy Alone in Unresectable Untreated Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A randomized, open-label, multicenter, phase 3 study of high-dose vitamin C plus FOLFOX +/- bevacizumab versus FOLFOX +/- bevacizumab in unresectable untreated metastatic colorectal cancer
Clin. Cancer Res 2022 Aug 05;[EPub Ahead of Print], F Wang, MM He, J Xiao, YQ Zhang, XL Yuan, WJ Fang, Y Zhang, W Wang, XH Hu, ZG Ma, YC Yao, ZX Zhuang, FX Zhou, JE Ying, Y Yuan, QF Zou, ZQ Guo, XY Wu, Y Jin, ZJ Mai, ZQ Wang, H Qiu, Y Guo, SM Shi, SZ Chen, HY Luo, DS Zhang, FH Wang, YH Li, RH XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.